About this trial
To develop and test liver cancer prevention educational material.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
At least 18 years old
Participants at the HOPE Clinic
Able to speak and read either English or Spanish
For usability testing: Able to use and navigate websites on own smart phone or study computer
Disqualifiers
Has been diagnosed with liver cancer
Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)
Trial population
Participants at HOPE Clinic
Trial design
Ecologic or community
Cross-sectional
Treatments tested in this trial
Cognitive Testing
BehavioralGiven by Survey and one-on one interviews
Usability Testing
BehavioralGiven by surveys and one-on-one interview.
Treatment groups
Trial outcomes
Primary outcomes
Cognitive Testing
Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational material. A trained research team member will ask probing questions throughout interviews as needed. Based on patient feedback, modifications will be made iteratively to the content to ensure the content is understood and interpreted as intended. There is no post-survey for cognitive testing.
Usability Testing
Usability will be measured qualitatively using a Usability Interview Guide. Usability will also be measured using the System Usability Scale. Acceptability will be measured with the Ottawa Acceptability Measures. Knowledge will be measured pre- and post- session using knowledge questions developed by the investigators and refined during cognitive testing.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
Cancer Prevention Research Institute of Texas
Collaborator